ZNF555 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.002170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.150200E-01
Normal-vs-Stage2
6.505800E-02
Normal-vs-Stage3
1.334150E-01
Normal-vs-Stage4
2.830800E-01
Stage1-vs-Stage2
4.455600E-01
Stage1-vs-Stage3
4.100000E-01
Stage1-vs-Stage4
1.350460E-02
Stage2-vs-Stage3
7.851200E-01
Stage2-vs-Stage4
5.630600E-04
Stage3-vs-Stage4
1.346200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.422200E-02
Normal-vs-AfricanAmerican
2.283800E-01
Normal-vs-Asian
1.621180E-01
Caucasian-vs-AfricanAmerican
8.581400E-01
Caucasian-vs-Asian
7.179600E-01
AfricanAmerican-vs-Asian
9.493800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.352230E-01
Normal-vs-Female
7.664000E-02
Male-vs-Female
5.442400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.472400E-01
Normal-vs-Age(41-60Yrs)
1.234570E-01
Normal-vs-Age(61-80Yrs)
1.121960E-01
Normal-vs-Age(81-100Yrs)
5.983800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.409600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.485200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.103800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.226400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.626000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.658200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.771960E-02
Normal-vs-Daily Drinker
2.037700E-02
Normal-vs-Weekly Drinker
2.774400E-01
Normal-vs-Occasional Drinker
2.093800E-01
Normal-vs-Social Drinker
2.022600E-01
Non Drinker-vs-Daily Drinker
4.282200E-01
Non Drinker-vs-Weekly Drinker
1.416620E-01
Non Drinker-vs-Occasional Drinker
1.565560E-01
Non Drinker-vs-Social Drinker
2.731400E-01
Daily Drinker-vs-Weekly Drinker
7.187900E-02
Daily Drinker-vs-Occasional Drinker
6.986400E-02
Daily Drinker-vs-Social Drinker
1.332200E-01
Weekly Drinker-vs-Occasional Drinker
8.864800E-01
Weekly Drinker-vs-Social Drinker
7.669000E-01
Occasional Drinker-vs-Social Drinker
8.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.135620E-01
Normal-vs-Grade 2
1.302470E-02
Normal-vs-Grade 3
2.419900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.576960E-01
Grade 1-vs-Grade 3
5.108400E-01
Grade 1-vs-Grade 4
1.135620E-01
Grade 2-vs-Grade 3
4.059600E-01
Grade 2-vs-Grade 4
1.302470E-02
Grade 3-vs-Grade 4
2.419900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.898300E-02
Normal-vs-NonDiabetic
6.845500E-02
Diabetic-vs-NonDiabetic
6.142800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.060100E-02
Normal-vs-NoPancreatitis
8.094200E-02
Pancreatitis-vs-NoPancreatitis
7.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.858050E-01
Normal-vs-N1
7.705700E-02
N0-vs-N1
4.463400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.982990E-01
Normal-vs-TP53-NonMutant
3.204800E-01
TP53-Mutant-vs-TP53-NonMutant
6.643600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
